Although bronchiolitis is the leading cause of hospitalization for US infants,[1](#jhm2318-bib-0001){ref-type="ref"} there is a lack of basic prospective data about the expected inpatient clinical course and ongoing uncertainty about when a hospitalized child is ready for discharge to home.[2](#jhm2318-bib-0002){ref-type="ref"} This lack of data about children\'s readiness for discharge may result in variable hospital length‐of‐stay (LOS).[3](#jhm2318-bib-0003){ref-type="ref"}, [4](#jhm2318-bib-0004){ref-type="ref"}, [5](#jhm2318-bib-0005){ref-type="ref"}

One specific source of variability in discharge readiness and LOS variability may be the lack of consensus about safe threshold oxygen saturation values for discharge in children hospitalized with bronchiolitis.[6](#jhm2318-bib-0006){ref-type="ref"}, [7](#jhm2318-bib-0007){ref-type="ref"} In 2006, the Scottish Intercollegiate Guidelines Network recommended a discharge room air oxygen (RAO2) saturation threshold of ≥95%.[8](#jhm2318-bib-0008){ref-type="ref"} The same year, the American Academy of Pediatrics (AAP) bronchiolitis clinical practice guideline stated that oxygen is not needed for children with RAO2 saturations ≥90% who are feeding well and have minimal respiratory distress.[9](#jhm2318-bib-0009){ref-type="ref"} There is a need for prospective studies to help clinicians make evidenced‐based discharge decisions for this common condition.

We performed a prospective, multicenter, multiyear study[10](#jhm2318-bib-0010){ref-type="ref"}, [11](#jhm2318-bib-0011){ref-type="ref"}, [12](#jhm2318-bib-0012){ref-type="ref"} to examine the typical inpatient clinical course of and to develop hospital discharge guidelines for children age \<2 years hospitalized with bronchiolitis. We hypothesized that children would not worsen clinically and would be safe to discharge home once their respiratory status improved and they were able to remain hydrated.

METHODS {#jhm2318-sec-0010}
=======

Study Design and Population {#jhm2318-sec-0011}
---------------------------

We conducted a prospective, multicenter cohort study for 3 consecutive years during the 2007 to 2010 winter seasons, as part of the Multicenter Airway Research Collaboration (MARC), a program of the Emergency Medicine Network (<http://www.emnet-usa.org>). The number of participating sites varied over the 3 years: 13 in year 1, 16 in year 2, and 14 in year 3. Each month from November 1 until March 31, site investigators across 12 US states used a standardized protocol to enroll a target number of consecutive patients from the inpatient wards and the intensive care unit (ICU). We aimed to enroll 20% of our total sample from the ICU. To over sample children in the ICU, the ward and ICU enrollments were separate. Once the site reached their target enrollment for that month, the investigators would stop enrollment until the beginning of the following month.

All patients were treated at the discretion of the treating physician. Inclusion criteria were an attending physician\'s diagnosis of bronchiolitis, age \<2 years, and the ability of the parent/guardian to give informed consent. The exclusion criteria were previous enrollment and transfer to a participating hospital \>48 hours after the original admission time. Therefore, children with comorbid conditions were included in this study. All consent and data forms were translated into Spanish. The institutional review board at each of the 16 participating hospitals approved the study.

Of the 2207 enrolled children, we excluded 109 (5%) children with a hospital LOS \<1 day due to inadequate time to capture the required data for the present analysis. Among the 2098 remaining children, 1916 (91%) had daily inpatient data on all factors used to define clinical improvement and clinical worsening. Thus, the analytic cohort was comprised of 1916 children hospitalized for bronchiolitis.

Data Collection {#jhm2318-sec-0012}
---------------

Investigators conducted detailed structured interviews. Chart reviews were conducted to obtain preadmission and daily hospital clinical data including respiratory rates, daily respiratory rate trends, degree of retractions, oxygen saturation, daily oxygen saturation trends, medical management, and disposition. These data were manually reviewed, and site investigators were queried about missing data and discrepancies. A follow‐up telephone interview was conducted with families 1 week after discharge to examine relapse events at both 24 hours and 7 days.

We used the question: "How long ago did the following symptoms \[eg, difficulty breathing\] begin \[for the\] current illness?" to estimate the onset of the current illness. Pulse was categorized as low, normal, or high based on age‐related heart rate values.[13](#jhm2318-bib-0013){ref-type="ref"} Presence of apnea was recorded daily by site investigators.[14](#jhm2318-bib-0014){ref-type="ref"}

Nasopharyngeal Aspirate Collection and Virology Testing {#jhm2318-sec-0013}
-------------------------------------------------------

As described previously, site teams used a standardized protocol to collect nasopharyngeal aspirates,[11](#jhm2318-bib-0011){ref-type="ref"} which were tested for respiratory syncytial virus (RSV) types A and B; rhinovirus (RV); parainfluenza virus types 1, 2, and 3; influenza virus types A and B; 2009 novel H1N1; human metapneumovirus; coronaviruses NL‐63, HKU1, OC43, and 229E; enterovirus, and adenovirus using polymerase chain reaction.[11](#jhm2318-bib-0011){ref-type="ref"}, [15](#jhm2318-bib-0015){ref-type="ref"}, [16](#jhm2318-bib-0016){ref-type="ref"}, [17](#jhm2318-bib-0017){ref-type="ref"}

Defining Clinical Improvement and Worsening {#jhm2318-sec-0014}
-------------------------------------------

Clinical improvement criteria were based on the 2006 AAP guidelines.[9](#jhm2318-bib-0009){ref-type="ref"} For respiratory rate and oxygen saturation, clinicians estimated average daily respiratory rate and oxygen saturation based on the recorded readings from the previous 24 hours. This estimation reflects the process clinicians use when rounding on their hospitalized patients, and thus may be more similar to standard clinical practice than a calculated mean. The respiratory rate criteria are adjusted for age.[18](#jhm2318-bib-0018){ref-type="ref"}, [19](#jhm2318-bib-0019){ref-type="ref"} For daily estimated average oxygen saturation we used the AAP criteria of RAO2 saturation of 90%. Considering that oxygen saturation is the main determinant of LOS,[20](#jhm2318-bib-0020){ref-type="ref"} healthy infants age \<6 months may have transient oxygen saturations of around 80%,[21](#jhm2318-bib-0021){ref-type="ref"} and that errors in estimation may occur, we included a lowest RAO2 of 88% in our improvement criteria. By combining the dichotomized estimated oxygen saturation (≥90% or not) with the lower limit of 88%, there was little room for erroneous conclusions. A child was considered clinically improved on the earliest date he/she met all of the following criteria: (1) none or mild retractions and improved or stable retractions compared with the previous inpatient day; (2) daily estimated average respiratory rate (RR) \<60 breaths per minute for age \<6 months, \<55 breaths/minute for age 6 to 11 months, and \<45 breaths/minute for age ≥12 months with a decreasing or stable trend over the course of the current day; (3) daily estimated average RAO2 saturation ≥90%, lowest RAO2 saturation ≥88%[21](#jhm2318-bib-0021){ref-type="ref"}; and (4) not receiving intravenous (IV) fluids or for children receiving IV fluids a clinician report of the child maintaining oral hydration. Children who reached the clinical improvement criteria were considered clinically worse if they required intensive care or had the inverse of ≥1 of the improvement criteria: moderate/severe retractions that were worse compared with the previous inpatient day, daily average RR ≥60 with an increasing trend over the current day, need for oxygen, or need for IV fluids.

Statistical Analyses {#jhm2318-sec-0015}
--------------------

All analyses were performed using Stata 12.0 (StataCorp, College Station, TX). Data are presented as proportions with 95% confidence intervals (95% CIs), means with standard deviations, and medians with interquartile ranges (IQR). To examine potential factors associated with clinical worsening after reaching clinical improvement, we used χ^2^, Fisher exact, Student *t* test, and Kruskall‐Wallis tests, as appropriate.

Adjusted analyses used generalized linear mixed models with a logit link to identify independent risk factors for worsening after reaching clinical improvement. Fixed effects for patient‐level factors and a random site effect were used. Factors were tested for inclusion in the multivariable model if they were found to be associated with worsening in unadjusted analyses (*P* \< 0.20) or were considered clinically important. Results are reported as odds ratios with 95% CIs.

We performed several sensitivity analyses to evaluate these improvement criteria: (1) we excluded the lowest RAO2 saturation requirement of 88%, (2) we examined a 94% daily estimated average RAO2 saturation threshold,[22](#jhm2318-bib-0022){ref-type="ref"} (3) we examined a 95% daily estimated average RAO2 saturation threshold,[8](#jhm2318-bib-0008){ref-type="ref"} and (4) we examined children age \<12 months with no history of wheeze.

RESULTS {#jhm2318-sec-0016}
=======

There were 1916 children hospitalized with bronchiolitis with data on all factors used to define clinical improvement and clinical worsening. The median number of days from the beginning of difficulty breathing until admission was 2 days (IQR, 1--5.5 days; range, 1--8 days) and from the beginning of difficulty breathing until clinical improvement was 4 days (IQR, 3--7.5 days; range, 1--33 days) (Figure [1](#jhm2318-fig-0001){ref-type="fig"}). The variance for days to admission was significantly less than the variance for days to clinical improvement (*P* \< 0.001).

![Time course of illness for children hospitalized with bronchiolitis.](JHM-10-205-g001){#jhm2318-fig-0001}

In this observational study, clinicians discharged 214 (11%) of the 1916 children before meeting the definition of clinical improvement. Thus, 1702 (89%; 95% CI: 87%‐90%) children reached the clinical improvement criteria, had a LOS \>1 day, and had data on all factors (Figure [2](#jhm2318-fig-0002){ref-type="fig"}).

![Flow diagram of the study population. \*Eight children were worsened on more than 1 criterion. Abbreviations: ICU, intensive care unit; IV, intravenous; LOS, length of stay; RR, respiratory rate.](JHM-10-205-g002){#jhm2318-fig-0002}

Of the 1702 children who met the clinical improvement criteria, there were 76 children (4%; 95% CI: 3%--5%) who worsened (Figure [2](#jhm2318-fig-0002){ref-type="fig"}). The worsening occurred within a median of 1 day (IQR, 1--3 days) of clinical improvement. Forty‐six (3%) of the children required transfer to the ICU (1 required intubation, 1 required continuous positive airway pressure, and 4 had apnea), 23 (1%) required oxygen, and 17 (1%) required IV fluids. Eight percent of children met multiple criteria for worsening. A comparison between children who did and did not worsen is shown in Table [1](#jhm2318-tbl-0001){ref-type="table"}. In general, children who worsened after improvement were younger and born earlier. These children also presented in more severe respiratory distress, had moderate or severe retractions, oxygen saturation \<85% at hospitalization, inadequate oral intake, and apnea documented during the hospitalization. Neither viral etiology nor site of care influenced whether the children worsened after improving. However, stratified analysis of children based on initial location of admission (ie, ICU or ward) showed that among the children admitted to the ICU from the emergency department (ED), 89% met the improvement criteria and 19% clinically worsened. In contrast, among children admitted to the ward from the ED, 89% met the improvement criteria, and only 2% clinically worsened. Stratified multivariable models based on the initial location of admission from the ED (ie, ICU or ward) were not possible due to small sample sizes after stratification. None of these children had relapse events requiring rehospitalization within either 24 hours or 7 days of discharge.

###### 

Characteristics of Children Who Did Not Worsen Versus Those Who Worsened After Clinical Improvement

                                                                                   Did Not Worsen, n = 1,626   Worsened, n = 76     *P* Value
  -------------------------------------------------------------------------------- --------------------------- -------------------- -----------
  Demographic characteristics                                                                                                       
   Age \<2 months, %                                                               29                          57                   \<0.001
   Month of birth, %                                                                                                                0.02
    October--March                                                                 61                          75                   
    April--September                                                               39                          25                   
   Sex, %                                                                                                                           0.51
    Male                                                                           59                          55                   
    Female                                                                         41                          45                   
   Race, %                                                                                                                          0.050
    White                                                                          63                          58                   
    Black                                                                          23                          34                   
    Other or missing                                                               14                          8                    
   Hispanic ethnicity, %                                                           37                          22                   0.01
   Insurance, %                                                                                                                     0.87
    Nonprivate                                                                     68                          67                   
    Private                                                                        32                          33                   
  Medical history                                                                                                                   
   Gestational age \<37 weeks, %                                                   23                          39                   0.002
   Birth weight, %                                                                                                                  0.52
    \<5 lbs                                                                        13                          12                   
    ≥5 lbs                                                                         34                          41                   
    ≥7 lbs                                                                         53                          47                   
   Mother\'s age, median (IQR)                                                     27 (23--33)                 27 (22--33)          0.54
   Is or was breastfed, %                                                          61                          51                   0.10
   Smoked during pregnancy, %                                                      15                          20                   0.22
   Exposure to smoke, %                                                            13                          20                   0.11
   Family history of asthma, %                                                                                                      0.89
    Neither parent                                                                 68                          64                   
    Either mother or father                                                        27                          30                   
    Both parents                                                                   4                           4                    
    Do not know/missing                                                            2                           1                    
   History of wheezing, %                                                          23                          17                   0.24
   History of eczema, %                                                            16                          7                    0.04
   History of intubation, %                                                        9                           12                   0.50
   Major, relevant, comorbid medical disorder, %                                   20                          24                   0.46
   Current illness                                                                                                                  
   When difficulty breathing began, preadmission, %                                0.63                                             
    ≥1 day                                                                         70                          75                   
    \<1 day                                                                        28                          23                   
    No difficulty preadmission                                                     2                           3                    
   Weight, lbs, median (IQR)                                                       12.3 (8.8--17.4)            9.0 (6.6--13.2)      0.001
   Temperature, °F, median (IQR)                                                   99.5 (98.6--100.6)          99.4 (98.1--100.4)   0.06
   Pulse, beats per minute by age                                                                                                   0.82
    Low                                                                            0.3                         0                    
    Normal                                                                         48                          46                   
    High                                                                           51                          54                   
   Respiratory rate, breaths per minute, median (IQR)                              48 (40--60)                 48 (38--64)          0.28
   Retractions, %                                                                                                                   0.001
    None                                                                           22                          25                   
    Mild                                                                           43                          24                   
    Moderate                                                                       26                          33                   
    Severe                                                                         4                           12                   
    Missing                                                                        5                           7                    
  Oxygen saturation by pulse oximetry or ABG, %                                    0.001                                            
    \<85                                                                           4                           12                   
    85--87.9                                                                       3                           4                    
    88--89.9                                                                       5                           0                    
    90--93.9                                                                       18                          11                   
    ≥94                                                                            72                          73                   
   Oral intake, %                                                                                                                   \<0.001
    Adequate                                                                       45                          22                   
    Inadequate                                                                     42                          63                   
    Missing                                                                        13                          14                   
   Presence of apnea, %                                                            7                           24                   \<0.001
   RSV‐A, %                                                                        44                          41                   0.54
   RSV‐B, %                                                                        30                          25                   0.36
   HRV, %                                                                          24                          24                   0.88
  Chest x‐ray results during ED/preadmission visit                                                                                  
    Atelectasis                                                                    12                          13                   0.77
    Infiltrate                                                                     13                          11                   0.50
    Hyperinflated                                                                  18                          21                   0.47
    Peribronchial cuffing/thickening                                               23                          17                   0.32
    Normal                                                                         14                          16                   0.75
   White blood count, median (IQR)                                                 11.2 (8.7--14.4)            11.9 (9.2--14.4)     0.60
   Platelet count, median (IQR)                                                    395 (317--490)              430 (299--537)       0.56
   Sodium, median (IQR)                                                            138 (136--140)              137 (135--138)       0.19
   Hospital length of stay, median (IQR)                                           2 (1--4)                    4.5 (2--8)           \<0.001
  One‐week follow‐up                                                                                                                
   Relapse within 24 hours of hospital discharge requiring hospital admission, %   0.5                         0                    0.56
   Relapse within 7 days of hospital discharge requiring hospital admission, %     1                           0                    0.35

NOTE: **Abbreviations:** ABG, arterial blood gas; ED, emergency department; HRV, human rhinovirus; IQR, interquartile range; RSV, respiratory syncytial virus.

On multivariable analysis (Table [2](#jhm2318-tbl-0002){ref-type="table"}), independent risk factors for worsening after reaching the clinical improvement criteria were young age, preterm birth, and presenting to care with more severe bronchiolitis represented by severe retractions, inadequate oral intake, or apnea. To further evaluate the improvement criteria in the current analysis, multiple sensitivity analyses were conducted. The frequency of clinical worsening after reaching the improvement criteria was stable when we examined different RA02 criteria in sensitivity analyses: (1) excluding RA02 as a criterion for improvement: 90% met improvement criteria and 4% experienced clinical worsening, (2) changing the average RA02 threshold for clinical improvement to 94%: 62% met improvement criteria and 6% experienced clinical worsening, and (3) changing the average RA02 threshold for clinical improvement to 95%: 47% met improvement criteria and 5% experienced clinical worsening. Furthermore, stratifying by age \<2 months and restricting to more stringent definitions of bronchiolitis (ie, age \<1 year or age \<1 year + no history of wheezing) also did not materially change the results (see Supporting Figure [1](#jhm2318-fig-0001){ref-type="fig"} in the online version of this article).

###### 

Multivariable Model of Factors Associated With a Worsening of Symptoms After Clinical Improvement.

                               Odds Ratio   95% CI        *P* Value
  ---------------------------- ------------ ------------- -----------
  Age \<2 months               3.51         2.07‐5.94     \<0.001
  Gestational age \<37 weeks   1.94         1.13‐3.32     0.02
  Retractions                                             
  None                         1.30         0.80‐3.23     0.19
  Mild                         1.0          Reference     ---
  Moderate                     1.91         0.99‐3.71     0.06
  Severe                       5.55         2.12--14.50   \<0.001
  Missing                      1.70         0.53‐5.42     0.37
  Oral intake                                             
  Adequate                     1.00         Reference     ---
  Inadequate                   2.54         1.39‐4.62     0.002
  Unknown/missing              1.88         0.79‐4.44     0.15
  Presence of apnea            2.87         1.45‐5.68     0.003

NOTE: **Abbreviations:** CI, confidence interval.

We compared the 214 children who were discharged prior to reaching clinical improvement with the 1702 children who reached the clinical improvement criteria. The 214 children were less likely to be age \<2 months (22% vs 30%; *P* = 0.02). These 2 groups (214 vs 1702) were similar with respect to severe retractions (2% vs 4%; *P* = 0.13), median respiratory rate (48 vs 48; *P* = 0.42), oxygen saturation \<90% (15% vs 11%; *P* = 0.07), inadequate oral intake (50% vs 43%; *P* = 0.13), and rates of relapse events requiring rehospitalization within both 24 hours (0.6% vs 0.6%; *P* = 0.88) and 7 days (1% vs 1%; *P* = 0.90) of discharge.

DISCUSSION {#jhm2318-sec-0017}
==========

In this large, multicenter, multiyear study of children hospitalized with bronchiolitis, we found that children present to a hospital in a relatively narrow time frame, but their time to recovery in the hospital is highly variable. Nonetheless, 96% of children continued to improve once they had: (1) improving or stable retractions rated as none/mild, (2) a decreasing or stable RR by age, (3) estimated average RAO2 saturation ≥90% and lowest RAO2 saturation of 88%, and (4) were hydrated. The 4% of children who worsened after clinically improving were more likely to be age \<2 months, born \<37 weeks, and present with more severe distress (ie, severe retractions, inadequate oral intake, or apnea). Based on the low risk of worsening after clinical improvement, especially among children admitted to the regular ward (2%), we believe these 4 clinical criteria could be used as discharge criteria for this common pediatric illness with a predominantly monophasic clinical course.

Variability in hospital LOS for children with bronchiolitis exists in the United States[3](#jhm2318-bib-0003){ref-type="ref"} and internationally.[4](#jhm2318-bib-0004){ref-type="ref"}, [5](#jhm2318-bib-0005){ref-type="ref"} Cheung and colleagues analyzed administrative data from over 75,000 children admitted for bronchiolitis in England between April 2007 and March 2010 and found sixfold variation in LOS between sites. They concluded that this LOS variability was due in part to providers\' clinical decision making.[5](#jhm2318-bib-0005){ref-type="ref"} Srivastava and colleagues[23](#jhm2318-bib-0023){ref-type="ref"} addressed variable clinician decision making in bronchiolitis and 10 other common pediatric conditions by embedding discharge criteria developed by expert consensus into admission order sets. They found that for children with bronchiolitis, the embedded discharge criteria reduced the median LOS from 1.91 to 1.87 days. In contrast to the single‐center data presented by White and colleagues,[24](#jhm2318-bib-0024){ref-type="ref"} the prospective, multicenter MARC‐30 data provide a clear understanding of the normal clinical course for children hospitalized with bronchiolitis, determine if children clinically worsen after clinical improvement, and provide data about discharge criteria for children hospitalized with bronchiolitis. Although there is a lack of rigorous published data, the lower tract symptoms of bronchiolitis (eg, cough, retractions) are said to peak on days 5 to 7 of illness and then gradually resolve.[25](#jhm2318-bib-0025){ref-type="ref"} In the present study, we found that the time from the onset of difficulty breathing until hospital admission is less variable than the time from the onset of difficulty breathing until either clinical improvement or discharge. Although 75% of children have clinically improved within 7.5 days of difficulty breathing based on the IQR results, the remaining 25% may have a more prolonged recovery in the hospital of up to 3 weeks. Interestingly, prolonged recovery times from bronchiolitis have also been noted in children presenting to the ED[26](#jhm2318-bib-0026){ref-type="ref"} and in an outpatient population.[27](#jhm2318-bib-0027){ref-type="ref"} It is unclear why 20% to 25% of children at different levels of severity of illness have prolonged recovery from bronchiolitis, but this group of children requires further investigation.

Given the variability of recovery times, clinicians may have difficulty knowing when a child is ready for hospital discharge. One of the main stumbling blocks for discharge readiness in children with bronchiolitis is the interpretation of the oxygen saturation value.[6](#jhm2318-bib-0006){ref-type="ref"}, [8](#jhm2318-bib-0008){ref-type="ref"}, [9](#jhm2318-bib-0009){ref-type="ref"}, [20](#jhm2318-bib-0020){ref-type="ref"}, [28](#jhm2318-bib-0028){ref-type="ref"} However, it should be considered that interpreting the oxygen saturation in a child who is clinically improving in the hospital setting is different than interpreting the oxygen saturation of a child in the ED or the clinic whose clinical course is less certain.[22](#jhm2318-bib-0022){ref-type="ref"} In the hospital setting, using the oxygen saturation value in in the AAP guideline,[9](#jhm2318-bib-0009){ref-type="ref"} 4% of children clinically worsened after they met the improvement criteria, a clinical pattern observed previously with supplemental oxygen.[28](#jhm2318-bib-0028){ref-type="ref"} This unpredictability may explain some of the variation in providers\' clinical decision making.[5](#jhm2318-bib-0005){ref-type="ref"} The children who worsened, and therefore deserve more cautious discharge planning, were young (\<2 months), premature (\<37 weeks gestational age), and presented in more severe distress. Those children admitted to the ICU from the ED worsened more commonly than children admitted to the ward (19% vs 2%). Interestingly, the viral etiology of the child\'s bronchiolitis did not influence whether a child worsened after reaching the improvement criteria. Therefore, although children with RV bronchiolitis have a shorter hospital LOS than children with RSV bronchiolitis,[11](#jhm2318-bib-0011){ref-type="ref"} the pattern of recovery did not differ by viral etiology.

In addition to unsafe discharges, clinicians may be concerned about the possibility of readmissions. Although somewhat controversial, hospital readmission is being used as a quality of care metric.[29](#jhm2318-bib-0029){ref-type="ref"}, [30](#jhm2318-bib-0030){ref-type="ref"}, [31](#jhm2318-bib-0031){ref-type="ref"} One response to minimize readmissions would be for clinicians to observe children for longer than clinically indicated.[32](#jhm2318-bib-0032){ref-type="ref"} However, shorter LOS is not necessarily associated with increased readmission rates.[33](#jhm2318-bib-0033){ref-type="ref"} Given that the geometric mean of hospital charges per child with bronchiolitis increased from \$6380 in 2000 to \$8530 in 2009,[34](#jhm2318-bib-0034){ref-type="ref"} the potential for safely reducing hospital LOS by using the discharge criteria proposed in the current study instead of other criteria[8](#jhm2318-bib-0008){ref-type="ref"} may net substantial cost savings. Furthermore, reducing LOS would decrease the time children expose others to these respiratory viruses and possibly reduce medical errors.[35](#jhm2318-bib-0035){ref-type="ref"}

Our study has some potential limitations. Because the study participants were all hospitalized, these data do not inform admission or discharge decisions from either the ED or the clinic; but other data address those clinical scenarios.[22](#jhm2318-bib-0022){ref-type="ref"} Also, the 16 sites that participated in this study were large, urban teaching hospitals. Consequently, these results are not necessarily generalizable to smaller community hospitals. Although numerous data points were required to enter the analytic cohort, only 9% of the sample was excluded for missing data. There were 214 children who did not meet our improvement criteria by the time of discharge. Although the inability to include these children in the analysis may be seen as a limitation, this practice variability underscores the need for more data about discharging hospitalized children with bronchiolitis. Last, site teams reviewed medical records daily. More frequent recording of the clinical course would have yielded more granular data, but the current methodology replicates how data are generally presented during patient care rounds, when decisions about suitability for discharge are often considered.

CONCLUSION {#jhm2318-sec-0018}
==========

We documented in this large multicenter study that most children hospitalized with bronchiolitis had a wide range of time to recovery, but the vast majority continued to improve once they reached the identified clinical criteria that predict a safe discharge to home. The children who worsened after clinical improvement were more likely to be younger, premature infants presenting in more severe distress. Although additional prospective validation of these hospital discharge criteria is warranted, these data may help clinicians make more evidence‐based discharge decisions for a common pediatric illness with high practice variation, both in the United States[3](#jhm2318-bib-0003){ref-type="ref"} and in other countries.[4](#jhm2318-bib-0004){ref-type="ref"}, [5](#jhm2318-bib-0005){ref-type="ref"}
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